RecruitingNot ApplicableNCT07063537

Feasibility, Accuracy, and Reproducibility of Virtual Reality Visual Field Testing in Patients With Glaucoma

Evaluation of the Accuracy and Reproducibility of Visual Field Testing Using a Virtual Reality Head-Mounted Device for Patients With Early, Moderate, and Advanced Glaucoma

Sponsor

Nova Scotia Health Authority

Enrollment

60 participants

Start Date

Dec 14, 2024

Study Type

INTERVENTIONAL

Conditions

Glaucoma, Open-Angle

Summary

The goal of this clinical trial is to evaluate the feasibility of using virtual reality based visual field testing to monitor glaucoma in a clinical setting. This will be done through comparison of a virtual reality (VR) based device to the current gold standard Ziess Humphrey Field Analyzer (HFA). The main questions the study aims to answer are: * Can both devices produce similar results in terms of detecting visual field defects and progression? * Does the stage (early, moderate, advanced) of glaucoma impact results between the two devices? Participants will perform both a standard and a VR based visual field test at each visit, for a total of 5 visits.

Eligibility

Min Age: 18 Years

Inclusion Criteria4

\>18 years of age
diagnosis of primary open-angle glaucoma
ability to perform visual field testing
capacity to provide informed consent to research protocol

Exclusion Criteria7

diagnosis of secondary glaucoma or non-glaucomatous optic neuropathy
previous intraocular surgery (excluding cataract surgery and minimally invasive glaucoma surgery)
significant media opacity
pregnancy
seizure disorder
cardiac pacemaker/other implantable device
severe vertigo/balance disorder

Interventions

DEVICEVirtual Reality Visual Field (VR-VF)

Both devices administer a standard visual field test. The Humphrey is the gold standard desk top model and the VR-VF is a virtual reality headset designed to deliver visual field testing